MicroRNA signature in liver cancer
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 219, 153369
Abstract
No abstract availableKeywords
Funding Information
- Shahid Beheshti University of Medical Sciences
This publication has 147 references indexed in Scilit:
- Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantationJournal of Cancer Research and Clinical Oncology, 2011
- miR-221 overexpression contributes to liver tumorigenesisProceedings of the National Academy of Sciences, 2009
- MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor MultifocalityClinical Cancer Research, 2009
- MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses TumorigenicityCancer Research, 2009
- Elevated Expression of the miR-17–92 Polycistron and miR-21 in Hepadnavirus-Associated Hepatocellular Carcinoma Contributes to the Malignant PhenotypeThe American Journal of Pathology, 2008
- MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinomaOncogene, 2008
- Identification of metastasis-related microRNAs in hepatocellular carcinomaHepatology, 2008
- Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient SurvivalClinical Cancer Research, 2008
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissuesOncogene, 2005